Market closed
Cibus Inc./$CBUS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
Ticker
$CBUS
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
158
Website
Cibus Inc. Metrics
BasicAdvanced
$69M
-
-$10.83
1.84
-
Price and volume
Market cap
$69M
Beta
1.84
52-week high
$2.73
52-week low
$1.40
Average daily volume
135K
Financial strength
Current ratio
0.853
Quick ratio
0.778
Long term debt to equity
32.147
Total debt to equity
37.09
Interest coverage (TTM)
-2.25%
Management effectiveness
Return on assets (TTM)
-10.76%
Return on equity (TTM)
-129.65%
Valuation
Price to revenue (TTM)
11.224
Price to book
0.64
Price to tangible book (TTM)
-0.3
Price to free cash flow (TTM)
-0.813
Growth
Revenue change (TTM)
134.56%
Earnings per share change (TTM)
-58.28%
3-year revenue growth (CAGR)
-45.26%
3-year earnings per share growth (CAGR)
-34.74%
Cibus Inc. News
AllArticlesVideos
Cibus to Report First Quarter 2025 Financial Results on May 8, 2025 After the Market Close and Host Conference Call
GlobeNewsWire·2 weeks ago
USDA-APHIS Designates Additional Cibus' Disease Resistance Trait Products as Not Regulated
GlobeNewsWire·2 weeks ago
Cibus, Inc. (CBUS) Q4 2024 Earnings Call Transcript
Seeking Alpha·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Cibus Inc. stock?
Cibus Inc. (CBUS) has a market cap of $69M as of May 07, 2025.
What is the P/E ratio for Cibus Inc. stock?
The price to earnings (P/E) ratio for Cibus Inc. (CBUS) stock is 0 as of May 07, 2025.
Does Cibus Inc. stock pay dividends?
No, Cibus Inc. (CBUS) stock does not pay dividends to its shareholders as of May 07, 2025.
When is the next Cibus Inc. dividend payment date?
Cibus Inc. (CBUS) stock does not pay dividends to its shareholders.
What is the beta indicator for Cibus Inc.?
Cibus Inc. (CBUS) has a beta rating of 1.84. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.